Warren Buffett increased his stake in Apple
- Institutional investors also bought shares of Microsoft
- Lantheus Holdings is a lesser-known but surging stock among institutional investors
Institutional investors’ portfolios often serve as a benchmark for individual portfolios. The 13F reports are mandatory for U.S. funds managing over $100 million and provide valuable insights. Note that these reports are published with a delay, meaning that the portfolio structure presented may significantly differ from the current state.
Popular with institutional investors are major technology companies such as Apple (NASDAQ:) and Microsoft Corporation (NASDAQ:). Another, lesser-known company, is Lantheus Holdings (NASDAQ:), which has recently surged.
With InvestingPro, we can understand why institutional investors are enthusiastically buying these three stocks.
You can start analyzing your choice of stocks with InvestingPro’s tools by clicking on the following link: Start analyzing stocks!
1. Apple
Chairman and CEO of Berkshire Hathaway, Warren Buffett, increased his stake in Apple, according to the recent 13F report.
Buffett now holds 915,560,382 shares of the American tech giant, increased by 20,424,207 shares.
Warren Buffett’s Portfolio Holdings
Source: InvestingPro
Using InvestingPro’s analysis tools, it’s hard to go against Warren Buffett’s decision. Apple has consistently strong profitability and revenue growth, contributing to its high score on the financial health index.
Source: InvestingPro
After a strong rebound, Apple’s next target is its historic highs in the $182 region.
2. Microsoft
Microsoft continues to grow in popularity among institutional investors, with the latest 13F report showing investment funds holding long positions nearly twice the number of short positions.
Microsoft’s earnings per share (EPS) of $9.73 are the highest among its competitors, and it ranks second in net earnings, with $72.334 billion, surpassed only by Apple.
Source: InvestingPro
3. Lantheus Holdings
Lantheus Holdings is a U.S. healthcare company that sells medical equipment and supplies.
Nicholas Investment, Oberweis Asset, and Eagle Health are among the investment firms holding shares in the company. Eagle Health focuses on the biotechnology sector and has delivered impressive returns over the past few years.
